Clinical Trials Directory

Trials / Completed

CompletedNCT00716963

Does Fluticasone Propionate Reduce the Late Allergic Reaction When the Drug is Given Post-allergen?

Does a Lipophilic Steroid Inhaled After an Early Allergic Reaction Affect the Late Reaction?

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The investigators propose a 3-treatment, placebo-controlled, double-dummy, double-blinded, randomized, crossover study in which single doses of placebo, will be compared to Fluticasone propionate (Flovent Diskus) 250 mcg and budesonide 400 mcg administered after allergen challenge, at cessation of the early allergic reaction (at 20% fall in FEV1 from post-allergen peak)

Detailed description

The aim of this pilot study is to evaluate whether fluticasone propionate affects the late allergic reaction after a single dose post-allergen challenge administered following cessation of the early allergic reaction. Six subjects with mild asthma will be asked to volunteer for the study.The diagnosis of asthma will be and includes the presence of variable airflow limitation and AHR (PC20 methacholine \< 16 mg/mL). Subjects will be asked to participate if they demonstrate an allergen-induced early and late asthmatic response of at least 20% and 15% reduction in FEV1, respectively. The study will consist of 4 periods, composed of a screening allergen period with 3 subsequent allergen challenge/treatment periods. Each period will be separated with a washout of at least 2 weeks. Subjects who demonstrate a dual asthmatic response in the screening period will be selected for randomization to treatment.

Conditions

Interventions

TypeNameDescription
DRUGFluticasone propionate (Flovent Diskus) 250 mcgFlovent Diskus 250 mcg
DRUGbudesonide 400 mcgbudesonide 400 mcg
OTHERPlaceboPlacebo

Timeline

Start date
2008-07-01
Primary completion
2008-11-01
Completion
2008-12-01
First posted
2008-07-16
Last updated
2018-05-29
Results posted
2015-05-15

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00716963. Inclusion in this directory is not an endorsement.